2 recruiting, 1 completed, 1 enrolling by invitation. 3 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Enrolling by invitation 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Finerenone Oral Tablet: new trials by email Literature Review of Finerenone Oral Tablet trials Research Report on Finerenone Oral Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure Finerenone Oral Tablet, Finerenone Placebo - Acute Heart Failure | Phase 4 | Recruiting | Juntendo University | 550 | 2026-05-11 | 2026-08-10 |
| Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study Semaglutide, 1.34 mg/mL, Finerenone Oral Tablet, Dapagliflozin (DAPA) - Type 2 DM, Type 2 DM /Diabetic Nephropathy | Phase 4 | Enrolling by invitation | Steno Diabetes Center Copenhagen | 50 | 2025-11-20 | 2025-12-22 |
| Finerenone for Patients With Primary Aldosteronism (FAIRY) Finerenone Oral Tablet, Spironolactone Oral Tablet - Primary Aldosteronism | Phase 4 | Completed | Chongqing Medical University | 306 | 2024-06-04 | 2026-09-25 |
| The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study Finerenone Oral Tablet, Placebo - Kidney Transplant; Complications | Phase 2 | Recruiting | University of North Carolina, Chapel Hill | 100 | 2024-04-23 | 2026-04-14 |
Albuminuria (2) · Heart Failure (1) · Hyperaldosteronism (1)
Chongqing Medical University (1) · Juntendo University (1) · Steno Diabetes Center Copenhagen (1) · University of North Carolina, Chapel Hill (1)
China (1) · Denmark (1) · Japan (1) · United States (1)
Amy Mottl, MD, MPH (1) · Peter Rossing, Clinical Professor (1) · Prabir Roy-Chaudhury, MD, PhD (1) · Shumin Yang (1) · Yuya Matsue, MD (1)